Sponsor Pipeline

Eric Lenze Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07623135
Lumateperone for Late-Life Depression		 Recruitment opened
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07623135 Lumateperone for Late-Life Depression Treatment Resistant Depression (TRD) Recruiting
Disease Areas
Depression (1)
Get alerts when Eric Lenze's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free